Geriatric information analysis of the molecular properties of mexidole

Geriatric information analysis of the molecular properties of mexidole

Objective: by using the pharmacoinformation profiling, to comprehensively assess all possible effects of the molecules of mexidol, choline alfoscerate, piracetam, glycine, and semax in accordance with the anatomical therapeutic and chemical (ATC) classification system.Material and methods. Chemoreac...

Full description

Bibliographic Details
Main Authors:	O. A. Gromova, I. Yu. Torshin, L. E. Fedotova
Format:	Article
Language:	Russian
Published:	IMA-PRESS LLC 2017-12-01
Series:	Неврология, нейропсихиатрия, психосоматика
Subjects:	geroprotection adverse reactions mexidol pharmacoinformatics artificial intelligence systems
Online Access:	https://nnp.ima-press.net/nnp/article/view/795

Similar Items

Geroprotective properties of neuroprotective and neurotrophic peptides
by: O. A. Gromova, et al.
Published: (2020-02-01)

Comparative chemoreactome analysis of mexidol
by: I. J. Torshin, et al.
Published: (2016-11-01)

Clinical and laboratory substantiation of Mexidol use in complex treatment of periodontitis in patients with peptic ulcers
by: Ostrovskaya L.U., et al.
Published: (2011-06-01)

Safety of Mexidol® (ethylmethylhydroxypyridine succinate) in adult patients of different age groups
by: E. A. Ushkalova, et al.
Published: (2022-10-01)

Influence Of Pentoxifylline And Mexidol On Lipid Peroxidation And Anti-oxidant System In Patients With Urolithiasis
by: A.B. Polozov, et al.
Published: (2009-12-01)

OXIDATIVE STRESS AND ITS PHARMACOLOGICAL CORRECTION by MEXIDOL IN TRAUMATIC BRAIN INJURY
by: N. V. Govorova
Published: (2016-02-01)

Effect of mexidol on lipid-phospholipid profile changes in elderly patients with stroke
by: Yu. V. Abramenko
Published: (2018-06-01)

CREATION AND PHARMACOTECHNOLOGICAL INVESTIGATIONS OF INNOVATIVE DOSAGE FORMS OF MEXIDOL
by: E. F. Stepanova, et al.
Published: (2019-01-01)

Coorection Of Lipid Peroxydation And Antioxydant Protective System By Mexidol And Glycine In Patients With Acute Ethanol Intoxication
by: R.S. Farshatov, et al.
Published: (2009-12-01)

Changes in lipid peroxidation and antioxidant system parameters in the liver of rats using mexidol in experimental obesity and bronchial asthma
by: O.P. Mialiuk, et al.
Published: (2022-02-01)

Effect of the 60-day introduction of tartrazine and mexidol on the ultrastructure of the rat’s parathyroid gland chief cells
by: V.I. Luzin, et al.
Published: (2023-12-01)

The effect of Mexidol on magnesium-calcium balance and endothelial dysfunction in operational stress
by: Baturin V.A., et al.
Published: (2014-03-01)

Electron microscopic features of thyroid parafollicular cells in rats after a 60-day administration of Tartrazine and Mexidol ®
by: Luzin, Vladyslav I., et al.
Published: (2023-06-01)

Chemoreactomic study of fonturacetam effects: molecular mechanisms of influence on adipose tissue metabolism
by: O. A. Gromova, et al.
Published: (2024-08-01)

Effect of the combination of mexidol and diclofenac sodium on exudative inflammation in rats after ten-day preventive oral administration
by: E. A. Ivanova, et al.
Published: (2022-05-01)

COMPARATIVE ANTICONVULSANT AND ANTIHYPOXIC EFFECTS OF ASTROKS AND MEXIDOL IN INJECTABLE FORM AND 2-ETHYL-6-METHYL-3-HYDROXYPYRIDINE SUCCINATE SUBSTANCE
by: T. A. Voronina, et al.
Published: (2016-06-01)

Theoretical insights into the antiradical activity and copper-catalysed oxidative damage of mexidol in the physiological environment
by: Nguyen Thi Hoa, et al.
Published: (2022-01-01)

MORPHOMETRIC PULMONIC INDICATORS USING MEXIDOL IN RATS WITH EXPERIMENTAL ACUTE RESPIRATORY DISTRESS SYNDROME
by: G. G. Makiev, et al.
Published: (2020-06-01)

Pharmacoinformational, basic and clinical studies of 7-hydroxymatairesinol in the context of searching for effective and safe therapeutic approaches to the treatment of mastopathy
by: А. N. Rubashkina, et al.
Published: (2024-06-01)

Research of free radical and tissue energy supply processes on rats subjected to concurrent Tetrachlormethane and Adrenaline impact after Mexidol administration
by: Kateryna Aleksevych, et al.
Published: (2015-03-01)

Lignan 7-hydroxymatairesinol in the context of post-genomic pharmacology
by: А. N. Rubashkina, et al.
Published: (2024-08-01)

Ultrastructure of thyrocytes, assessment of their functional state after prolonged exposure to sodium benzoate and simulation of bone fractures and justification for the effectiveness of mexidol and selenase
by: Vitalii N. Morozov
Published: (2024-09-01)

The positive and negative effects of using transdermal nonsteroidal anti-inflammatory drugs: chemoreactome analysis
by: I. Yu. Torshin, et al.
Published: (2020-10-01)

Molecular pharmacology of coenzyme Q10 in the context of treatment of hyperlipidemic conditions
by: O. A. Gromova, et al.
Published: (2023-07-01)

Effect of multiple-dose regimens of cyclooxygenase inhibitors and their combinations with mexidol on behavior in mature rats
by: E. A. Ivanova, et al.
Published: (2023-05-01)

Proteomic analysis of synergetic neuroprotective effect of adenosine, thiamine, niacin and cyanocobalamin in pathophysiology of diabetic polyneuropathy
by: O. A. Gromova, et al.
Published: (2025-02-01)

Comparative chemomicrobiomic analysis of bacteriocins
by: I. Yu. Torshin, et al.
Published: (2024-02-01)

Chemoinformatic study of spiramycin in comparison with other antibiotics
by: O. A. Gromovа, et al.
Published: (2023-09-01)

Possibilities of using coenzyme Q10 for the treatment of diseases associated with mitochondrial dysfunction and chronic inflammation
by: O. A. Gromova, et al.
Published: (2023-11-01)

Identification of potent inhibitors of SARS-CoV-2 infection by combined pharmacological evaluation and cellular network prioritization
by: J.J. Patten, et al.
Published: (2022-09-01)

Comparative evaluation of influence of drugs with antioxidant effect on therapeutic efficiency of radiotherapy and oxidative status in mice
by: Masyagin V.A., et al.
Published: (2012-12-01)

Identification of novel MCM2 inhibitors from Catharanthus roseus by pharmacoinformatics, molecular docking and molecular dynamics simulation-based evaluation
by: K.M. Salim Andalib, et al.
Published: (2023-01-01)

Metabolomics-based phenotypic screens for evaluation of drug synergy via direct-infusion mass spectrometry
by: Xiyuan Lu, et al.
Published: (2022-05-01)

A computational framework of host-based drug repositioning for broad-spectrum antivirals against RNA viruses
by: Zexu Li, et al.
Published: (2021-03-01)

Cell autocloning as a pathway to their real rejuvenation
by: Lev Salnikov
Published: (2024-07-01)

Chemoreactomic analysis of acyzole in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
by: P. A. Galenko-Yaroshevsky, et al.
Published: (2024-05-01)

CLINICAL ASPECTS OF ETHYLMETHYLHYDROXYPYRIDINE SUCCINATE IN ELDERLY PATIENTS WITH CARDIOVASCULAR PATHOLOGY
by: E. G. Martemianova
Published: (2018-04-01)

Cognitive impairments as a universal clinical syndrome in a therapist's practice
by: V N Shishkova
Published: (2014-11-01)

Chemoreactome prediction of anti-inflammatory, analgesic, ulcerogenic effects of the candidate molecule N-allylimidazole-zinc in comparison with zinc derivatives of nonsteroidal anti-inflammatory drugs
by: P. A. Galenko-Yaroshevsky, et al.
Published: (2025-02-01)

Computer analysis of the emotional modality of 20 million publications in PUBMED database indicates ways to increase the effectiveness of pharmacotherapy by identifying pseudoscientific publications aimed at negative emotional "pumping" of doctors
by: V. A. Maximov, et al.
Published: (2021-06-01)